NY Select Drug List

The following list of drugs are carved out of the inpatient payment and are reimbursed separately.

A separate claim must be submitted to receive reimbursement for the drug administered during an inpatient hospital stay:

• Certain drugs that are designated "By Report" ("BR") must be submitted on the Medical Assistance Health Insurance Claim Form New York State eMedNY-150003 (PDF).
• If the drug is not listed with “BR” in the chart below, the claim can be submitted electronically.

Refer to the New York State Medicaid General Billing Guidelines (PDF) for professional claims.

Providers may not utilize 340B inventory for NY Medicaid members for those drugs listed on the NY Select Drug List.

• List is also available in the following formats: Portable Document Format (PDF) - Excel (XLSX)

Drug	Generic name	Therapeutic Class	By Report (BR)
Abecma	idecabtagene vicleucel	(CAR) T Therapy
Adstiladrin	nadofaragene firadenovec-vncg	Gene therapy	BR
Breyanzi	lisocabtagene maraleucel	(CAR) T Therapy
Carvykti	ciltacabtagene autoleucel	(CAR) T Therapy
Casgevy	exagamglogene autotemcel	Gene therapy	BR
Elevidys	delandistrogene moxeparvovec-rokl	Gene therapy	BR
Hemgenix	etranacogene dezaparvovec-drlb	Gene therapy	BR
Kymriah	tisagenlecleucel	(CAR) T Therapy
Lenmeldy	atidarsagene autotemcel	Gene therapy	BR
Luxturna	voretigine neparvovec-rzyl	Gene therapy
Lyfgenia	lovotibeglogene autotemcel	Gene therapy	BR
Skysona	elivaldogene autotemcel	Gene therapy	BR
Tecartus	brexucabtagene autoleucel	(CAR) T Therapy
Yescarta	axicabtagene ciloleucel	(CAR) T Therapy
Zolgensma	onasemnogene abeparvovec-xioi	Gene therapy	BR
Zynteglo	betibeglogene autotemcel	Gene therapy	BR